Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for NEURELIS, INC. · Biopharmaceutical company specializing in treatments for neurological conditions.

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 17, 2026
Income
$10,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).

 Bills named in this filing 4

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem